| Literature DB >> 30524661 |
Prangmalee Leurcharusmee1,2,3, Passakorn Sawaddiruk1,2,3, Yodying Punjasawadwong2, Nipon Chattipakorn1,3, Siriporn C Chattipakorn1,3,4.
Abstract
Ischemia and reperfusion (I/R) injury induced by tourniquet (TQ) application leads to the release of both oxygen free radicals and inflammatory cytokines. The skeletal muscle I/R may contribute to local skeletal muscle and remote organ damage affecting outcomes after total knee arthroplasty (TKA). The aim of the study is to summarize the current findings associated with I/R injury following TKA using a thigh TQ, which include cellular alterations and protective therapeutic interventions. The PubMed database was searched using the keywords "ischemia reperfusion injury," "oxidative stress," "tourniquet," and "knee arthroplasty." The search was limited to research articles published in the English language. Twenty-eight clinical studies were included in this qualitative review. Skeletal muscle I/R reduces protein synthesis, increases protein degradation, and upregulates genes in cell stress pathways. The I/R of the lower extremity elevates local and systemic oxidative stress as well as inflammatory reactions and impairs renal function. Propofol reduces oxidative injury in this I/R model. Ischemic preconditioning (IPC) and vitamin C may prevent oxygen free radical production. However, a high dose of N-acetylcysteine possibly induces kidney injury. In summary, TQ-related I/R during TKA leads to muscle protein metabolism alteration, endothelial dysfunction, oxidative stress, inflammatory response, and renal function disturbance. Propofol, IPC, and vitamin C show protective effects on oxidative and inflammatory markers. However, a relationship between biochemical parameters and postoperative clinical outcomes has not been validated.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30524661 PMCID: PMC6247434 DOI: 10.1155/2018/8087598
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Effects of TQ-induced I/R injury on localized skeletal muscles.
| Study model/specimen/sample size/age | TQ pressure/ischemia time | Major findings (compared to baseline level) | Interpretation | References | ||
|---|---|---|---|---|---|---|
| Clinical outcome | Mechanism | |||||
| Ischemia phase | Reperfusion phase | |||||
| Cross-sectional study/vastus lateralis muscle biopsy/ | ≥300 mmHg, 32–52 min | ↓ 12% of quadriceps muscle volume at 2 weeks after surgery | ↔ eIF4G gene expression | ↑ eIF4G gene expression | Cap-dependent translation initiation and elongation may be inhibited during skeletal muscle I/R | [ |
| Randomized controlled trial/vastus medialis muscle biopsy/ | 380 mmHg, 60 min | N/A | ↔ free, conjugated Ub | N/A | Upregulated proteasome-dependent and -independent peptidase activities suggested an increase in protein degradation at 60-minute ischemia time | [ |
| Randomized controlled trial/vastus lateralis muscle biopsy/ | Double SBP mmHg, 56–92 min | N/A | ↑ all muscle-free amino acids, except glutamate | ↓ all muscle-free amino acids | Degradation of free amino acids was more than synthesis during skeletal muscle ischemia | [ |
| Cross-sectional study/vastus lateralis muscle biopsy/ | ≥300 mmHg, 33–50 min | N/A | N/A | Upregulation of 72 genes including JAK-STAT, p53, JNK, NF | Genes related to cell stress pathways involved in reperfusion injury | [ |
| Cross-sectional study/quadriceps muscle biopsy, venous blood/ | 300 mmHg | N/A | ↑ positive ET-1-immunostaining cells | ↑ positive ET-1-immunostaining cells | ET-1 is involved in skeletal muscle I/R | [ |
| Cross-sectional study/quadriceps muscle biopsy/ | 300 mmHg | N/A | ↔ nNOS, iNOS, and eNOS immunostaining in muscle fibers | ↑ nNOS and eNOS immunostaining in muscle fibers | nNOS and eNOS were upregulated in postischemic muscle, but their activities were not altered | [ |
| Randomized controlled trial/interstitial space fluid at gastrocnemius muscle/ | 250 mmHg, 74 ± 4 min | N/A | ↓ glucose | ↓ glucose | Changes in the level of metabolic markers in the extracellular space suggested ischemic injury and persisted for up to 180 minutes after reperfusion | [ |
| Randomized controlled trial/vastus medialis muscle biopsy/ | 380 mmHg, 60 min | N/A | ↔ mitochondrial enzymes | N/A | No effects on amount and function of mitochondria at 60-minute ischemia time | [ |
4E-BP1: eukaryotic initiation factor 4E-binding protein; eEF2: eukaryotic elongation factor 2; eIF4G: eukaryotic translation initiation factor 4 gamma; ET-1: endothelin 1; I/R: ischemia and reperfusion; JAK-STAT: Janus kinase/signal transducer and activator of transcription; JNK: c-Jun N-terminal kinase; L/P: lactate/pyruvate; MAPK: mitogen-activated protein kinase; mRNA: messenger ribonucleic acid; N/A: not available; NFκB: nuclear factor kappa-light-chain-enhancer of activated B cells; NOS: nitric oxide synthase; SBP: systolic blood pressure; TQ: tourniquet; Ub: ubiquitin.
Effects of TQ-induced I/R injury on local and systemic circulation.
| Study model/specimen/sample size/age | TQ pressure/ischemia time | Main findings (compared to baseline level) | Interpretation | References | ||
|---|---|---|---|---|---|---|
| Clinical outcome | Mechanism | |||||
| Local circulation | Systemic circulation | |||||
| Randomized controlled trial/antecubital venous blood/ | 250 mmHg, approx. 90 ± 15 min | N/A | Surgical drainage tube | Antecubital vein | Changes in glutathione oxidation and lipid peroxidation happened earlier and more intensely in the blood from the reperfused area than from the systemic circulation | [ |
| Cross-sectional study/antecubital and femoral venous blood/ | Double SBP mmHg, 85 ± 8 min | N/A | Femoral vein of operated leg | Antecubital vein | Higher increase in prooxidants and oxidative stress in the blood from the reperfused area compared to the systemic circulation | [ |
| Cross-sectional study/great saphenous venous blood of both legs, blood from surgical drain/ | 250–300 mmHg, 78–125 min | N/A | Surgical drainage tube | Great saphenous vein of nonoperated leg | Higher increase in pro- and anti-inflammatory cytokines in the blood from the reperfused area compared to the systemic circulation | [ |
| Cross-sectional study/peripheral blood lymphocytes/ | 100–120 min | N/A | N/A | ↑ genotoxicity index | Genotoxic and cytotoxic effects on peripheral lymphocytes were most pronounced at onset of reperfusion and remained so 1 hour afterward | [ |
| Case-control study/venous blood/ | 250–300 mmHg, 80 ± 20 min | ↑ knee function scores | N/A | ↑ IL-6, CPR, CPK, and white cell count | Oxidative stress after TKA surgery primarily originated from surgical stress only | [ |
CPK: creatine phosphokinase; CRP: c-reactive protein; GSH: reduced glutathione; GSSG: oxidized glutathione; IL: interleukin; I/R: ischemia and reperfusion; MDA: malondialdehyde; N/A: not available; SBP: systolic blood pressure; TKA: total knee arthroplasty; TQ: tourniquet; XO: xanthine oxidase.
Effects of TQ-induced I/R injury on remote organs.
| Sample size/age | TQ pressure/ischemia time | Main findings (compared to baseline level) | Interpretation | References | |
|---|---|---|---|---|---|
| Outcomes on remote organ | Systemic effects | ||||
|
| 91 ± 11 min, N/A | Heart: | ↑ serum MDA | No cardiac muscle injury after TKA with TQ | [ |
|
| N/A | Brain: | ↑ plasma lactate | No adverse effects on regional cerebral oxygenation, pulmonary oxygenation, and renal function after TKA with TQ | [ |
|
| 250 mmHg, 52 ± 11 min | Lungs: | ↑ serum IL-6, TNF- | No lung injury occurred as indicated by the unaltered marker of elastin breakdown after TKA with TQ | [ |
|
| 300–350 mmHg, 83–121 min | Kidney: | ↑ plasma lactate | Possible proximal tubular injury after TKA with TQ | [ |
AST: aspartate aminotransferase; CPK: creatinine phosphokinase; CRP: c-reactive protein; Cr: creatinine; GST-α: glutathione-S-transferase-α; IL: interleukin; LDH: lactate dehydrogenase; MDA: malondialdehyde; N/A: not available; NAG: N-acetyl-β-D-glucosaminidase; PF ratio: ratio of arterial oxygen partial pressure to fractional inspired oxygen; POCD: postoperative cognitive dysfunction; rScO2: regional cerebral oxygen saturation; TKA: total knee arthroplasty; TNF: tumor necrosis factor; TQ: tourniquet; WBC: white blood cell.
Effects of ischemic preconditioning (IPC) and remote IPC (rIPC) on TQ-induced I/R injury in TKA.
| Study model/specimen/TQ pressure | IPC protocol/TQ ischemia time/sample size/age | Main findings (compared to control) | Interpretation | References | ||
|---|---|---|---|---|---|---|
| Intervention | Control | Clinical outcome | Mechanism | |||
| RCT/antecubital venous blood, quadriceps muscle biopsy, SBP + 100 mmHg | 3 cycles of 5 min ischemia and 5 min reperfusion at operated thigh, 68–87 min, | no IPC, 68–87 min, | N/A | ↑ gene expression | IPC induced a protective genomic response | [ |
| Case-control study/quadriceps muscle biopsy | N/A, | No IPC, | N/A | Altered expression of genes involved in neurological system process and regulation of neuron apoptosis | IPC induced a protective genomic response | [ |
| RCT/venous blood, urine/250 mmHg | 1 cycle of 5 min ischemia and 5 min reperfusion at operated thigh, 58 ± 11 min, | no IPC, 52 ± 11 min, | ↓ median pain scores within 48 h after surgery | ↔ serum IL-6, TNF- | IPC did not prevent systemic inflammatory response or the level of lung injury | [ |
| RCT/venous blood, blood from surgical drain/250 mmHg | 1 cycle of 5 min ischemia and 5 min reperfusion at operated thigh, 48 min (IQR 13), | no IPC, 54 min (IQR 18), | ↓ pain scores within 48 h after surgery | ↔ intraarticular IL-6, TNF- | IPC may improve postoperative pain control | [ |
| RCT/arterial blood, venous blood/double SBP mmHg | 3 cycles of 5 min ischemia at nonoperated thigh, | No IPC, | Brain: | ↓ serum LDH | Remote IPC improved regional cerebral and pulmonary oxygenation possibly via a decrease in tissue damage | [ |
| Cross-sectional study/venous blood/double SBP mmHg | Approx. 60 min ischemia at previously operated thigh, 62 ± 19 min, | First-operated knee, 63 ± 14 min, | N/A | Tend to ↓ whole blood ROS production | Remote IPC may occur during bilateral TKA with sequential application of TQ | [ |
| Cross-sectional study/venous blood | Approx. 90 min ischemia at previously operated thigh, 89 ± 9 min, | First-operated knee, 91 ± 11 min, | N/A | Tend to ↓ serum MDA | Remote IPC may occur during bilateral TKA with sequential application of TQ | [ |
| Cross-sectional study/venous blood (dorsum of each foot)/double SBP mmHg | Approx. 60 min ischemia at previously operated thigh with 20 min reperfusion, 62 ± 19 min, | First-operated knee (right), 61 ± 5 min, | Muscle: | ↔ serum MDA | Sequential ischemic surgical procedure did not reduce oxidative injury after reperfusion | [ |
AST: aspartate aminotransferase; CPK: creatinine phosphokinase; CRP: c-reactive protein; Cr: creatinine; IL: interleukin; ESR: erythrocyte sedimentation rate; IPC: ischemic preconditioning; I/R: ischemia and reperfusion; IQR: interquantile range; LDH: lactate dehydrogenase; MDA: malondialdehyde; N/A: not available; PCOOH: phosphatidylcholine hydroperoxide; PF ratio: ratio of arterial oxygen partial pressure to fractional inspired oxygen; POCD: postoperative cognitive dysfunction; RCT: randomized controlled trial; ROS: reactive oxygen species; rScO2: regional cerebral oxygen saturation; SBP: systolic blood pressure; TKA: total knee arthroplasty; TNF: tumor necrosis factor; TQ: tourniquet; WBC: white blood cell; WOMAC: Western Ontario and McMaster University Osteoarthritis Index.
Effects of anesthetic agents on TQ-induced I/R injury in TKA.
| Study model/specimen/TQ pressure | Anesthetic agent/dose/TQ ischemia time/sample size/age | Main findings (compared between groups) | Interpretation | References | ||
|---|---|---|---|---|---|---|
| Intervention | Control | Clinical outcome | Mechanism | |||
| RCT/venous blood/350 mmHg | Propofol, 2 mg/kg/h, 90 ± 7 min, | Normal saline, 0.2 ml/kg/h, 93 ± 10 min, | Sedation effect | Plasma SOD, TCA | Sedation dose of propofol has antioxidative and anti-inflammatory properties | [ |
| RCT/arterial blood/double SBP mmHg | Propofol, 0.2 mg/kg then 2 mg/kg/h, 72 ± 18 min, | Midazolam, 5 mg, 69 ± 14 min, | N/A | Whole blood ROS production | Sedation dose of propofol attenuates ROS production compared to midazolam | [ |
| RCT/venous blood | Propofol, 2–2.5 mg/kg then 6–10 mg/kg/h, 79 ± 13 min, | Sevoflurane, 1.5–2%, 83 ± 15 min, | N/A | Serum MDA | Propofol reduces oxidative injury in the TQ-induced I/R model | [ |
| RCT/arterial blood, venous blood/350–400 mmHg | Propofol, 2 mg/kg then 4–8 mg/kg/h, 114 ± 19 min, | Halothane, 0.7–1%, 116 ± 25 min, | MAP, pH, PaO2, PaCO2 | Serum MDA | Propofol reduces oxidative injury in the TQ-induced I/R model | [ |
hsCRP: high-sensitivity C-reactive protein; I/R: ischemia and reperfusion; MAP: mean arterial pressure; MDA: malondialdehyde; N/A: not available; PaCO2: arterial carbon dioxide partial pressure; PaO2: arterial oxygen tension; RCT: randomized controlled trial; ROS: reactive oxygen species; SBP: systolic blood pressure; SOD: superoxide dismutase; TAC: total antioxidative capacity; TQ: tourniquet.
Effects of pharmacological intervention on TQ-induced I/R injury in TKA.
| Study model/specimen/TQ pressure | Drug/dose/TQ ischemia time/sample size/age | Main findings (compared between groups) | Interpretation | References | |
|---|---|---|---|---|---|
| Intervention | Control | ||||
| RCT/venous blood | Vitamin C, 0.03 g/kg during ischemia then 0.01 g/kg after reperfusion, 91 ± 11 min, | Normal saline, 91 ± 14 min, | Serum MDA | High-dose vitamin C prevents oxygen free radical production and may have myocardial protection properties | [ |
| RCT/vastus lateralis muscle biopsy/double SBP mmHg | Mannitol, 930 mosmol/kg, 12.5 mL/kg/day, 75–93 min, | 5% glucose, 18.75 mL/kg/day, 50–88 min, | Muscle GSH, tGSH | No positive effects of mannitol in this TQ-induced I/R model | [ |
| RCT/venous blood, quadriceps femoris muscle biopsy/300 mmHg | iNO, 80 ppm entire operation, 101 ± 20 min, | Nitrogen, 95 ± 19 min, | Plasma ICAM, VCAM | No beneficial effects of iNO in this TQ-induced I/R model | [ |
| RCT/antecubital venous blood/200 mmHg | Lower O2 tension, FiO2 = 0.4, 61–110 min, | Higher O2 tension, FiO2 = 0.5, 86–107 min, | Plasma isofurans | Elevated O2 tension during general anesthesia reflects increased oxidative stress | [ |
| RCT/venous blood, urine/300–350 mmHg | NAC, 150 mg/kg before ischemia then 6.25 mg/kg/h during ischemia, 77–113 min, | 5% glucose, 83–121 min, | Urine | High-dose NAC may aggravate proximal tubular injury | [ |
Cr: creatinine; FiO2: fraction of inspired oxygen; GSH: reduced glutathione; ICAM: intercellular adhesion molecule; iNO: inhaled nitric oxide; I/R: ischemia and reperfusion; MDA: malondialdehyde; NAC: N-acetylcysteine; NAG: N-acetyl-β-D-glucosaminidase; RCT: randomized controlled trial; tGSH: total glutathione; TQ: tourniquet; VCAM: vascular adhesion molecule.
Figure 1Effects of tourniquet- (TQ-) induced I/R injury on localized skeletal muscle, circulation, and remote organs and the effects of therapeutic interventions on the skeletal muscle I/R in cases of surgery for knee arthroplasty (TKA). The skeletal muscle I/R condition results in (1) preserved cellular bioenergy and mitochondrial function, (2) upregulation of genes related to cell stress pathways, (3) endothelial dysfunction as indicated by an increase in endothelin 1 and NOS levels, (4) alteration in protein metabolism, (4) increased oxidative stress and inflammatory responses, and (5) injury to distant organs including the kidney. Ischemic preconditioning (IPC), propofol, and vitamin C demonstrated positive or protective effects in the cases of I/R injury in this setting, while elevated O2 tension aggravated the injury and N-acetylcysteine may have dose-dependent responses. Other interventions including remote ischemic preconditioning (rIPC), volatile anesthetic agents, mannitol, and nitric oxide possibly produce positive outcomes, and additional studies in this I/R condition should be investigated. ⊕: positive effect; ⊖: negative effect; ?: inadequate evidence; ↑: increase; ↓: decrease; ↔: no change; ATP: adenosine triphosphate; CPK-MB: creatinine phosphokinase-MB; Cr: creatinine; eNOS: endothelial nitric oxide synthase; nNOS: neuronal nitric oxide synthase; O2: oxygen.